Skip to content

    Kymera Therapeutics (KYMR) stock price & financials

    View KYMR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+179.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $3.74M
    $7.39M
    $22.10M
    $11.48M
    $2.76M
    -26.1%
    $2.87M
    -61.2%
    $34.37M
    +55.5%
    $65.00M
    +466.4%
    Strengthening
    Operating Profit
    -$72.12M
    -$80.75M
    -$74.43M
    -$84.56M
    -$92.52M
    -28.3%
    -$97.89M
    -21.2%
    -$84.15M
    -13.1%
    -$75.61M
    +10.6%
    Weakening
    Net Profit
    -$62.49M
    -$70.75M
    -$65.58M
    -$76.61M
    -$82.17M
    -31.5%
    -$86.98M
    -22.9%
    -$69.23M
    -5.6%
    -$61.21M
    +20.1%
    Stable
    EPS
    $-0.82
    $-0.82
    $-0.95
    $-0.94
    -14.6%
    $-0.71
    +13.4%
    $-0.62
    +34.7%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -1927.9%
    -1092.2%
    -336.8%
    -736.8%
    -3347.4%
    -73.6%
    -3409.8%
    -212.2%
    -244.9%
    +27.3%
    -116.3%
    +84.2%
    Weakening
    Tax
    ReturnsROIC
    5.2%
    5.9%
    5.5%
    6.4%
    6.9%
    +31.5%
    7.3%
    +22.9%
    5.8%
    +5.6%
    5.1%
    -20.1%
    Stable

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$76.02M$31.00M$47.98M$68.39M$109.97M$120.26M$357.01M$124.48M
    Short-Term Investments
    Total Current Assets$92.84M$302.34M$451.27M$419.42M$405.32M$510.27M$871.21M$737.26M
    Net PP&E$22.08M$20.69M$21.31M$22.24M$101.08M$97.86M$85.53M$81.07M
    Goodwill
    Intangibles
    Total Assets$116.70M$487.18M$605.90M$603.13M$575.76M$978.03M$1.74B$1.65B
    LiabilitiesTotal Current Liabilities$34.57M$110.62M$92.54M$71.34M$85.69M$67.77M$83.21M$71.33M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$16.65M$14.13M$13.22M$12.15M$77.03M$72.42M$67.03M$64.02M
    Total Liabilities$82.03M$203.29M$146.27M$112.98M$180.79M$142.42M$163.15M$136.19M
    EquityCommon Stock & APIC$4.0K$5.0K$6.0K$6.0K$7.0K$8.0K$8.0K
    Retained Earnings-$76.46M-$128.76M-$228.98M-$383.79M-$530.75M-$754.61M-$1.07B-$1.20B
    Total Equity-$74.41M$283.89M$459.64M$490.15M$394.97M$835.62M$1.58B$1.51B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$17.91M$88.13M-$128.95M-$153.09M-$102.83M-$194.50M-$232.89M-$236.76M
    Cash from Investing-$16.49M-$422.59M-$99.83M$20.52M$139.89M-$404.08M-$521.06M-$752.49M
    Cash from Financing$34.91M$289.26M$250.28M$153.00M$4.19M$608.85M$990.71M$777.92M
    SummaryCapital Expenditure-$532.0K-$9.10M-$1.60M-$2.84M-$34.48M-$12.84M-$1.45M-$1.19M
    Free Cash Flow$17.37M$79.03M-$130.54M-$155.92M-$137.31M-$207.34M-$234.34M-$237.96M
    FCF Margin592.1%232.2%-179.2%-333.0%-174.7%-440.5%-597.6%-226.6%

    Ratios